Diabetes and Obesity Care
Bend, Oregon, 97702, United States
Location status: Recruiting
Location contact
Eden Miller, D.O.
CONTACT
NCT Number: NCT06921902
The FreeStyle Libre 3 Continuous Glucose Monitoring (FSL3) System is used to characterize the glycemic profiles of people with and without a prediabetes diagnosis.
Interested in participating?
Request Info18 year and older
All sexes
Observational
Bend, Oregon, 97702, United States
Location status: Recruiting
Eden Miller, D.O.
CONTACT
This is a non-pivotal, non-randomized, multi-center, prospective, non-significant risk to evaluate the glycemic profiles of people with and without a prediabetes diagnosis using continuous glucose monitoring. Up to 2000 subjects will be enrolled in up to 20 sites. Approximately 50% of evaluable subjects will have a prediabetes diagnosis.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Abbott Sensor Based Glucose Monitoring System (FreeStyle Libre 3 System)
Other names: FreeStyle Libre 3 Monitoring System
Time frame: up to 50 days
This is a data collection study.
Contact information is provided by the study sponsor or research team.
Abbott Diabetes Care
Industry
Observation and Identification of Glycemic Metrics and Patterns in People With and Without Prediabetes (PREMAP)
Acronym: PREMAP
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07713030
Behavior, Diabetes Mellitus
Lahore, Punjab Province, Pakistan
View Trial DetailsNCT07118098
Autoimmune Diseases, Diabetes Mellitus
Vienna, Austria
View Trial DetailsNCT06426277
Diabetes Mellitus, Endocrine System Diseases
Goiânia, Goiás, Brazil
View Trial DetailsNCT07111026
Behavior, Behavioral Symptoms
Ellenton, Georgia, United States
View Trial Details